Get started Log in

CPRX — Catalyst Pharmaceuticals News Story

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Market Cap
$3.85bn
Enterprise Value
$3.10bn
Revenue
$588.99m

Brief: Catalyst Pharmaceuticals Q3 Revenue USD 102.7 Million Vs. IBES Estimate USD 100.4 Million

Catalyst Pharmaceuticals

08/11/2023 21:11

Nov 08 (Reuters) - Catalyst Pharmaceuticals Q3 adjusted net income USD 55.9
million.
* outlook FY revenue USD 390-395 million

Recent news on Catalyst Pharmaceuticals

Deals of the day-Mergers and acquisitions
16/07/2026 20:35
Deals of the day-Mergers and acquisitions
16/07/2026 14:34
Deals of the day-Mergers and acquisitions
16/07/2026 10:37
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
16/07/2026 10:28
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
16/07/2026 10:03